• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.

作者信息

Kurebayashi J, Sonoo H, Shimozuma K

机构信息

Department of Endocrine Surgery, Kawasaki Medical School, Okayama, Japan.

出版信息

Surg Today. 1995;25(6):519-24. doi: 10.1007/BF00311308.

DOI:10.1007/BF00311308
PMID:7579959
Abstract

It has been suggested that the timing of surgery during periods of unopposed estrogen circulation, when high blood levels of estrogen and low blood levels of progesterone exist, has a deleterious effect on the survival of premenopausal patients with breast cancer. We studied this controversial issue by examining the serum estradiol and progesterone levels of 38 premenopausal patients with primary breast cancer, and by analyzing data on 100 premenopausal patients treated for primary breast cancer. The survival of 31 patients who had undergone initial surgery between days 3 and 12 after their last menstrual period (group E) was compared with that of 69 patients who had undergone surgery between days 0 and 2 or from 13 days after their last menstrual period (group P). The overall survival of group E was significantly worse than that of group P (P = 0.049). This difference was especially notable in patients with node-positive tumors or tumors larger than 2 cm in size; however there was no significant difference in disease-free survival between the two groups. On a multivariate analysis, nodal status was the only significant prognostic factor for both overall and disease-free survival. Thus, these findings suggest that unopposed estrogen circulation may be detrimental to the overall survival of premenopausal women with breast cancer.

摘要

相似文献

1
Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.
Surg Today. 1995;25(6):519-24. doi: 10.1007/BF00311308.
2
A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.一项关于绝经前乳腺癌手术时激素环境的前瞻性预后研究。
Cancer. 2001 May 15;91(10):1854-61.
3
Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.绝经前乳腺癌患者的生存情况与手术时的月经周期时间及原发肿瘤的雌激素受体/孕激素受体状态的关系。
Cancer. 1999 Nov 15;86(10):2053-8. doi: 10.1002/(sici)1097-0142(19991115)86:10<2053::aid-cncr24>3.0.co;2-h.
4
Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer.绝经前可手术乳腺癌女性患者手术时的血清孕酮水平与生存情况
Eur J Cancer. 1994;30A(4):445-8. doi: 10.1016/0959-8049(94)90415-4.
5
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.月经周期期间手术时机与可手术乳腺癌绝经前女性的生存率
Lancet. 1991 May 25;337(8752):1261-4. doi: 10.1016/0140-6736(91)92927-t.
6
Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer.可手术乳腺癌的绝经前女性手术时机与月经周期的关系
Br J Surg. 1994 Feb;81(2):217-20. doi: 10.1002/bjs.1800810219.
7
Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer.对于绝经前雌激素受体阳性的II期乳腺癌患者,术后使用丝裂霉素C、他莫昔芬和优福定进行化疗 - 内分泌治疗是有效的。日本西部乳腺癌辅助治疗协作研究组。
Breast Cancer Res Treat. 1999 Jul;56(2):113-24. doi: 10.1023/a:1006221425652.
8
Menstrual timing of treatment for breast cancer.乳腺癌治疗的月经时机
J Natl Cancer Inst Monogr. 1994(16):85-90.
9
Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients.
Biomed Pharmacother. 2001;55 Suppl 1:133s-137s. doi: 10.1016/s0753-3322(01)90018-6.
10
[The prognostic significance of cathepsin D in primary breast cancer].[组织蛋白酶D在原发性乳腺癌中的预后意义]
Geburtshilfe Frauenheilkd. 1994 Oct;54(10):545-51. doi: 10.1055/s-2007-1022337.

引用本文的文献

1
Timing of breast surgery in premenopausal breast cancer patients.绝经前乳腺癌患者乳房手术的时机
Cochrane Database Syst Rev. 2011 May 11;2011(5):CD003720. doi: 10.1002/14651858.CD003720.pub2.
2
Timing of surgery during the menstrual cycle and prognosis of breast cancer.月经周期中手术时机与乳腺癌预后
J Biosci. 2000 Mar;25(1):113-20. doi: 10.1007/BF02985188.

本文引用的文献

1
Optimal timing of breast cancer surgery: findings revive debate.
J Natl Cancer Inst. 1993 Apr 21;85(8):605-7. doi: 10.1093/jnci/85.8.605.
2
Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer.
Int J Cancer. 1993 Feb 20;53(4):707-8. doi: 10.1002/ijc.2910530430.
3
Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer.可手术乳腺癌的绝经前女性手术时机与月经周期的关系
Br J Surg. 1994 Feb;81(2):217-20. doi: 10.1002/bjs.1800810219.
4
Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.孕激素对抗雌激素耐药的人T47DCO乳腺癌细胞的生长抑制及胰岛素受体增加作用:对内分泌治疗的意义
Cancer Res. 1985 Jan;45(1):167-73.
5
Menstrual influence on surgical cure of breast cancer.月经对乳腺癌手术治疗的影响。
Lancet. 1989 Oct 21;2(8669):949-52. doi: 10.1016/s0140-6736(89)90956-2.
6
Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival.
Ann Intern Med. 1991 Sep 1;115(5):337-42. doi: 10.7326/0003-4819-115-5-337.
7
Optimal mastectomy timing.最佳乳房切除术时机。
J Natl Cancer Inst. 1992 Mar 4;84(5):346-8. doi: 10.1093/jnci/84.5.346.
8
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.月经周期期间手术时机与可手术乳腺癌绝经前女性的生存率
Lancet. 1991 May 25;337(8752):1261-4. doi: 10.1016/0140-6736(91)92927-t.
9
Tamoxifen reduces serum insulin-like growth factor I (IGF-I).他莫昔芬可降低血清胰岛素样生长因子I(IGF-I)水平。
Breast Cancer Res Treat. 1992;22(1):91-100. doi: 10.1007/BF01833337.